These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12506021)

  • 21. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
    Samuelsson A; Towers TL; Ravetch JV
    Science; 2001 Jan; 291(5503):484-6. PubMed ID: 11161202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
    Imbach P; Morell A
    Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
    Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR
    Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    Blood; 2002 Sep; 100(6):2087-93. PubMed ID: 12200371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
    Smith B; Christodoulou L; Clargo A; Eddleston A; Greenslade K; Lightwood D; Shock A; Tyson K; Brennan FR
    Int Immunopharmacol; 2019 Jan; 66():362-365. PubMed ID: 30529500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbalpha antibodies.
    Webster ML; Sayeh E; Crow M; Chen P; Nieswandt B; Freedman J; Ni H
    Blood; 2006 Aug; 108(3):943-6. PubMed ID: 16861348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura.
    Aubin E; Lemieux R; Bazin R
    Br J Haematol; 2007 Mar; 136(6):837-43. PubMed ID: 17341270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.
    Mott PJ; Lazarus AH
    PLoS One; 2013; 8(6):e65805. PubMed ID: 23785450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of IVIG in ITP.
    Lazarus AH
    Vox Sang; 2002 Aug; 83 Suppl 1():53-5. PubMed ID: 12617104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
    Crow AR; Song S; Freedman J; Helgason CD; Humphries RK; Siminovitch KA; Lazarus AH
    Blood; 2003 Jul; 102(2):558-60. PubMed ID: 12649142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
    Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
    Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura.
    Yanabu M; Nomura S; Fukuroi T; Suzuki M; Kawakatsu T; Kido H; Yamaguchi K; Kokawa T; Yasunaga K
    Br J Haematol; 1993 Aug; 84(4):694-701. PubMed ID: 8217830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
    Deng R; Balthasar JP
    Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS; Sun DS; Lien TS; Chang HH
    Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
    Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia.
    Nishimoto T; Satoh T; Takeuchi T; Ikeda Y; Kuwana M
    Exp Hematol; 2012 Apr; 40(4):279-89. PubMed ID: 22240606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.